What is the life expectancy for someone with osteogenesis imperfecta (OI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The life expectancy for someone with osteogenesis imperfecta (OI) varies significantly depending on the type and severity of the condition, with most people with mild forms having a normal or near-normal life expectancy, while those with severe forms may have a shortened lifespan due to respiratory problems and other complications 1.

Factors Affecting Life Expectancy

The primary factors affecting longevity in OI patients include:

  • Respiratory function
  • Skeletal deformities
  • Frequency of fractures Early diagnosis, comprehensive care from multidisciplinary teams, and preventive measures to avoid fractures and complications are essential for maximizing both quality of life and life expectancy for people with OI.

Severity of OI and Life Expectancy

The severity of OI plays a significant role in determining life expectancy, with:

  • Mild forms (Type I) having a normal or near-normal life expectancy
  • Moderate forms (Types IV, V, VI, and VII) having a relatively normal lifespan with appropriate medical care
  • Severe forms (Type II and Type III) having a shortened lifespan due to respiratory problems and other complications

Recent Advances in Treatment

Recent advances in treatment, including bisphosphonate medications, surgical interventions, physical therapy, and improved respiratory support, have significantly improved life expectancy for OI patients over the past few decades 1.

Importance of Pulmonary Function Guidance

Pulmonary function guidance is crucial in OI patients, as respiratory impairment can significantly impact quality of life and life expectancy, and may be overlooked in milder cases 1.

From the Research

Osteogenesis Imperfecta Life Expectancy

  • Life expectancy for individuals with osteogenesis imperfecta (OI) can vary greatly depending on the severity of the condition and the quality of care received 2.
  • With modern treatment approaches, including bisphosphonates, physical therapy, and orthopedic surgery, many individuals with OI can lead active and fulfilling lives, although life expectancy may still be reduced compared to the general population 3, 4, 5.
  • The severity of OI, which can range from mild to severe, plays a significant role in determining life expectancy, with more severe forms of the disease often associated with shorter life spans 2.
  • Advances in medical and surgical management, such as the use of bisphosphonates to increase bone mineral density and reduce fracture risk, have improved the outlook for individuals with OI, potentially leading to increased life expectancy 3, 6.
  • Multidisciplinary care, including physical therapy, medical treatment, and orthopedic surgery as necessary, is crucial for improving quality of life and potentially extending life expectancy for individuals with OI 5.

Factors Influencing Life Expectancy

  • The number and severity of fractures, as well as the presence of other complications such as spinal deformities and basilar impression, can impact life expectancy 4, 2.
  • Early intervention and aggressive treatment, including the use of bisphosphonates and orthopedic surgery, may help improve life expectancy by reducing the risk of fractures and other complications 3, 4, 6.
  • Ongoing research into new treatments, such as innovative therapies targeting the specific altered pathways in OI, may offer further hope for improving life expectancy and quality of life for individuals with this condition 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta.

Current osteoporosis reports, 2017

Research

Osteogenesis imperfecta: treatment and surgical management.

Current opinion in pediatrics, 2021

Research

Bisphosphonate therapy for osteogenesis imperfecta.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.